Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

MuseCells under the microscope: 5-Year registry tracks Real-World outcomes

NCT ID NCT07645989

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry follows 5000 people who have received Dezawa MuseCells as part of their routine care for conditions like osteoarthritis, pain, and wound healing. Participants report their symptoms and any side effects through online surveys over five years. The goal is to understand the long-term safety and effectiveness of this cell therapy in real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dezawa MuseCells
What this could lead to
If successful, this registry could reveal whether MuseCells provide lasting symptom relief and safety for various conditions, guiding future treatments.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. Long-term benefits or risks remain uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who have undergone treatment with Dezawa MuseCells

Ages

Up to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Received Dezawa MuseCells® as Part of Routine Clinical Care 2. Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up. 3. Willingness to Complete Online Survey Assessments 4. Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period. 5. Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions. 6. Ability to Communicate in the Registry's Supported Language 7. Participants must be able to read and respond to registry surveys in the designated study language. 8. Enrollment Within 12 Months of MuseCell® Administration Exclusion Criteria: 1. Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included. 2. Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf. 3. Inability to Participate in Long-Term Digital Follow-Up 4. Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes 5. History of Malignancy Diagnosed Within the Past 12 Months 6. Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns. 7. Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality 8. Use of Non-Licensed or Counterfeit "Muse-like" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods. 9. Pregnant or Actively Breastfeeding at Time of Enrollment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Longevity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation injury osteoarthritis Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Bioreset Medical

    RECRUITING

    North Palm Beach, Florida, 33408, United States

    Contact Email: •••••@•••••

  • Regene Labs

    RECRUITING

    Guadalajara, Mexico

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.